Dual Improvement of Alopecia Areata and Immune Thrombocytopenia With Baricitinib: A Case Report
January 2025
in “
Skin Health and Disease
”
TLDR Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.
A 56-year-old man with alopecia areata (AA) and immune thrombocytopenia (ITP) experienced significant hair regrowth and normalized platelet counts after 14 months of treatment with baricitinib, an oral Janus kinase inhibitor. This case suggests a potential autoimmune link between AA and ITP and indicates that baricitinib could be an effective treatment for both conditions, though regular platelet monitoring and collaboration with hematology specialists are necessary. Further large-scale studies are required to confirm the safety and efficacy of baricitinib for ITP management.
